Tidal Investments’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$534K Buy
19,091
+6,034
+46% +$170K ﹤0.01% 2059
2026
Q1
$373K Buy
13,057
+117
+0.9% +$3.99K ﹤0.01% 1954
2025
Q4
$512K Sell
12,940
-516
-4% -$18.9K ﹤0.01% 1631
2025
Q3
$474K Sell
13,456
-682
-5% -$23.5K ﹤0.01% 1597
2025
Q2
$463K Sell
14,138
-5,576
-28% -$181K ﹤0.01% 1446
2025
Q1
$636K Sell
19,714
-1,450
-7% -$53.8K 0.01% 1204
2024
Q4
$647K Buy
21,164
+189
+0.9% +$6.08K 0.01% 1241
2024
Q3
$588K Hold
20,975
0.01% 1299
2024
Q2
$478K Buy
+20,975
New +$484K 0.01% 1328

Other funds holding ATRC

Tidal Investments's ATRC Position: Q2 2026 in Review

Tidal Investments increased its AtriCure (ATRC) stake by 46% in Q2 2026, buying an estimated $170K and bringing the position to 19,091 shares worth $534K. The position accounts for ﹤0.01% of the portfolio, ranked #2059.

Tidal Investments first reported a position in ATRC in Q2 2024 and has held it in 9 quarters since. The position peaked at $647K in Q4 2024. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Tidal Investments held 19,091 shares of AtriCure worth $534K as of Q2 2026.
  • Tidal Investments bought 6,034 AtriCure shares in Q2 2026, an estimated $170K.
  • AtriCure made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #2059 holding.
  • Tidal Investments first reported a position in AtriCure in Q2 2024 and has held it in 9 quarters since.
  • Tidal Investments's AtriCure position peaked at $647K in Q4 2024.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.